The emerging role of AMP-activated protein kinase in cholestatic liver diseases

被引:24
作者
Li, Xiaojiaoyang [1 ,2 ]
Liu, Runping [2 ]
Zhang, Luyong [1 ,3 ]
Jiang, Zhenzhou [1 ,4 ]
机构
[1] China Pharmaceut Univ, Jiangsu Key Lab Drug Screening, Nanjing, Jiangsu, Peoples R China
[2] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA
[3] Guangdong Pharmaceut Univ, Sch Pharm, Ctr Drug Screening & Pharmacodynam Evaluat, Guangzhou, Guangdong, Peoples R China
[4] China Pharmaceut Univ, Key Lab Drug Qual Control & Pharmacovigilance, Minist Educ, Nanjing, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
AMP-activated protein kinase; Cholestasis; Fibrosis; Liver injury; FARNESOID X RECEPTOR; BILE-ACID-HOMEOSTASIS; HEPATIC STELLATE CELLS; 17-ALPHA-ETHINYLESTRADIOL-INDUCED CHOLESTASIS; OBSTRUCTIVE-CHOLESTASIS; INTESTINAL MICROBIOTA; INSULIN-RESISTANCE; SIGNALING PATHWAY; IN-VIVO; INJURY;
D O I
10.1016/j.phrs.2017.09.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
AMP-activated protein kinase (AMPK), recognized as an energy sensor with three heterotrimeric subunits (alpha, beta and gamma), not only maintains basal intracellular adenosine triphosphate levels but also regulates energy-intensive pathological responses, such as neurodegenerative and metabolic diseases, through multiple signaling pathways. Recent studies open a new direction for AMPK research and demonstrate that AMPK is a critical player in the pathogenesis of cholestatic liver injury and plays paradoxical roles in the regulation of different pathological processes, including the disruption of bile acid homeostasis and the regulation of hepatic polarity, inflammation and fibrosis. In the present review, we summarize recent findings that implicate AMPK-mediated signaling pathways in the pathogenesis of cholestatic liver injury. These findings provide novel insight regarding the potential use of AMPK as a therapeutic target for the treatment of cholestatic liver injury. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:105 / 113
页数:9
相关论文
共 87 条
[1]   Gut microbiota, tight junction protein expression, intestinal resistance, bacterial translocation and mortality following cholestasis depend on the genetic background of the host [J].
Alaish, Samuel M. ;
Smith, Alexis D. ;
Timmons, Jennifer ;
Greenspon, Jose ;
Eyvazzadeh, Daniel ;
Murphy, Ebony ;
Shea-Donahue, Terez ;
Cirimotich, Shana ;
Mongodin, Emmanuel ;
Zhao, Aiping ;
Fasano, Alessio ;
Nataro, James P. ;
Cross, Alan .
GUT MICROBES, 2013, 4 (04) :292-305
[2]   Bile Acids Induce Inflammatory Genes in Hepatocytes A Novel Mechanism of Inflammation during Obstructive Cholestasis [J].
Allen, Katryn ;
Jaeschke, Hartmut ;
Copple, Bryan L. .
AMERICAN JOURNAL OF PATHOLOGY, 2011, 178 (01) :175-186
[3]  
Bao W., 2017, J CELLULARBIOCHEM
[4]  
Biyyani R.S., 2009, BMJ CASE REPORTS
[5]   Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells [J].
Caligiuri, Alessandra ;
Bertolani, Cristiana ;
Guerra, Cristina Tosti ;
Aleffi, Sara ;
Galastri, Sara ;
Trappoliere, Marco ;
Vizzutti, Francesco ;
Gelmini, Stefania ;
Laffi, Giacomo ;
Pinzani, Massimo ;
Marra, Fabio .
HEPATOLOGY, 2008, 47 (02) :668-676
[6]   Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice (Publication with Expression of Concern) [J].
Carvalho, B. M. ;
Guadagnini, D. ;
Tsukumo, D. M. L. ;
Schenka, A. A. ;
Latuf-Filho, P. ;
Vassallo, J. ;
Dias, J. C. ;
Kubota, L. T. ;
Carvalheira, J. B. C. ;
Saad, M. J. A. .
DIABETOLOGIA, 2012, 55 (10) :2823-2834
[7]   HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer [J].
Chang, Hae Ryung ;
Nam, Seungyoon ;
Kook, Myeong-Cherl ;
Kim, Kyung-Tae ;
Liu, Xiuping ;
Yao, Hui ;
Jung, Hae Rim ;
Lemos, Robert, Jr. ;
Seo, Hye Hyun ;
Park, Hee Seo ;
Gim, Youme ;
Hong, Dongwan ;
Huh, Iksoo ;
Kim, Young-Woo ;
Tan, Dongfeng ;
Liu, Chang-Gong ;
Powis, Garth ;
Park, Taesung ;
Liang, Han ;
Kim, Yon Hui .
GUT, 2016, 65 (01) :19-+
[8]   Cellular Energy Depletion Resets Whole-Body Energy by Promoting Coactivator-Mediated Dietary Fuel Absorption [J].
Chopra, Atul R. ;
Kommagani, Ramakrishna ;
Saha, Pradip ;
Louet, Jean-Francois ;
Salazar, Christina ;
Song, Junghun ;
Jeong, Jaewook ;
Finegold, Milton ;
Viollet, Benoit ;
DeMayo, Franco ;
Chan, Lawrence ;
Moore, David D. ;
O'Malley, Bert W. .
CELL METABOLISM, 2011, 13 (01) :35-43
[9]   AMPK as a Therapeutic Target for Treating Metabolic Diseases [J].
Day, Emily A. ;
Ford, Rebecca J. ;
Steinberg, Gregory R. .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2017, 28 (08) :545-560
[10]   Cholestatic jaundice associated with the use of metformin [J].
Desilets, DJ ;
Shorr, AF ;
Moran, KA ;
Holtzmuller, KC .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (07) :2257-+